Skip to main content

January 10th – Birmingham, Michigan – CitySide Ventures announces adding Adlore inc. to its portfolio of companies.

Birmingham Angels, a CitySide’s Angels syndicate of angel investors, just closed a round of investment in Adlore inc. A medical device company that invented an innovative product to help diabetics to maninat the necessary temperature at the lower legs to avoid serious issues.   

“We are pleased to help address this huge medical issue. Diabetic foot ulcer treatment is between $9 billion and is about $13 Billion Annually.” – David P. Weaver – Chief Investment Officer at CitySide Ventures.

Birmingham Angels’ goal is to become a premier Investment group committed to taking Michigan Angel investing to a new level by building a network of active, progressive and innovative investors committed to turning Michigan into a powerhouse startup ecosystem.

For more information about Birmingham Angels please visit us at:

If you are an accredited investor and would like to schedule a private meeting,

please complete the following request form:

or contact us:; 248.236.7005 Ext. 704